Improving sample delivery for X-ray analysis of biomolecules
Structural Dynamics at LCLS
This study is working on improving how scientists send samples to a special X-ray facility so they can quickly replace any samples that get damaged, helping them better understand important molecules like proteins in real-time.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11057647 on NIH RePORTER |
What this research studies
This research focuses on enhancing the methods used to deliver samples for analysis at the Linac Coherent Light Source (LCLS), a powerful X-ray facility. It addresses the challenge of sample destruction caused by high-intensity X-ray pulses by developing advanced injector systems that can rapidly replace damaged samples. These injectors allow for the collection of data on biomolecules, such as membrane proteins, in real-time, enabling researchers to study their structures and dynamics more effectively. The approach aims to facilitate new types of experiments that require precise timing and sample handling.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with conditions related to biomolecular dysfunction, such as certain genetic disorders or diseases that affect protein function.
Not a fit: Patients with conditions unrelated to biomolecular structures or those who do not have access to the specific technologies used in this research may not benefit.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in understanding the structures and functions of important biomolecules, potentially impacting drug design and therapeutic strategies.
How similar studies have performed: Previous research utilizing similar injector-based sample delivery methods has shown promise in advancing our understanding of biomolecular structures, indicating a potential for success in this area.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Hunter, Mark — Stanford University
- Study coordinator: Hunter, Mark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.